{"nct_id":"NCT01957007","title":"A Study of Vantictumab (OMP-18R5) in Combination With Docetaxel in Patients With Previously Treated NSCLC","status":"COMPLETED","status_verified_date":"2020-09","start_date":"2013-09","start_date_type":null,"primary_completion_date":"2016-12","primary_completion_date_type":"ACTUAL","completion_date":"2017-06","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MREO"]}